¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"focal sclerosing glomerulopathy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulopathy
    Å丮º´Áõ, »ç±¸Ã¼º´Áõ
  • subacute sclerosing panencephalitis
    ¾Æ±Þ¼º°æÈ­¹ü³ú¿°
  • sclerosing
    °æÈ­-
  • sclerosing adenosis
    °æÈ­»ùÁõ, °æÈ­¼±Áõ
  • sclerosing agent
    °æÈ­Á¦
  • sclerosing angioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°, °æÈ­´ã°ü¿°
  • sclerosing epithelial hamartoma
    °æÈ­Ç¥Çǰú¿ÀÁ¾
  • sclerosing fibrosis
    °æÈ­¼¶À¯Áõ
  • sclerosing gastritis
    °æÈ­À§¿°
  • sclerosing hemangioma
    °æÈ­Ç÷°üÁ¾
  • sclerosing inflammation
    °æÈ­¿°Áõ
  • sclerosing keratitis
    °æÈ­°¢¸·¿°
  • sclerosing liposarcoma
    °æÈ­Áö¹æÀ°Á¾
  • sclerosing mastoiditis
    °æÈ­²ÀÁöµ¹±â¿°, °æÈ­À¯µ¹¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulopathy
    Å丮º´Áõ, »ç±¸Ã¼º´Áõ
  • focal epilepsy
    ¿îµ¿ÁßÃß¼Õ»ó°£Áú, ÃÊÁ¡°£Áú
  • focal segmental glomerulosclerosis
    ±¹¼ÒÁ¶°¢Å丮±»À½Áõ, ±¹¼ÒºÐÀý»ç±¸Ã¼°æÈ­Áõ
  • sclerosing agent
    °æÈ­Á¦
  • sclerosing cholangitis
    °æÈ­¾µ°³°ü¿°
  • sclerosing
    °æÈ­-
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulopathy
    Å丮º´Áõ, »ç±¸Ã¼º´Áõ
  • focal distance
    ÃÊÁ¡°Å¸®
  • principal focal distance
    ÁÖÃÊÁ¡°Å¸®
  • focal epilepsy
    ¿îµ¿ÁßÃß¼Õ»ó°£Áú
  • focal
    ±¹¼Ò-, ÃÊÁ¡-, º´ÅÍ-
  • focal glomerulonephritis
    ÃÊÁ¡Å丮ÄáÆÏ¿°, ÃÊÁ¡»ç±¸Ã¼½Å¿°
  • focal hyperkeratosis
    ±¹¼Ò°¢È­°ú´ÙÁõ
  • focal infection
    ±¹¼Ò°¨¿°
  • focal length
    ÃÊÁ¡°Å¸®, ÃÊÁ¡±æÀÌ
  • focal lesion
    ±¹¼Òº´ÅÍ
  • focal point
    ÃÊÁ¡
  • focal seizure
    ÃÊÁ¡°£Áú, ÃÊÁ¡¼º¹ßÀÛ
  • focal spasticity
    ±¹¼Ò°æÁ÷
  • focal spot
    ÃÊÁ¡
  • focal convulsive seizure
    ÃÊÁ¡°æ·Ã¹ßÀÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulopathy
    »ç±¸Ã¼º´Áõ.
  • adenosis, sclerosing
    °æÈ­¼º ¼±Á¾(ÌãûùàõàÍðþ)
  • garres sclerosing osteomyelitis
    °æÈ­¼º °ñ¼ö¿°
  • hereditary sclerosing poikiloderma
    À¯Àü¼º °æÈ­¼º ´ÙÇüÇǺÎÁõ
  • histoplasmosis,sclerosing
    °æÈ­¼º
  • primary sclerosing cholangitis
    ¿ø¹ß(¼º) °æÈ­¼º ´ã°ü¿°(¡­ÌãûùàõÓÅηæú).
  • primary sclerosing cholangitis
    ¿ø¹ß(¼º) °æÈ­¼º ´ã°ü¿°(ê«Û¡(àõ) Ìãûùàõ ÓÅηæú)
  • radial sclerosing lesion
    ¹æ»ç¼º °æÈ­¼º º´º¯
  • Focal distance, principal
    ÃÊÁ¡(õ¥ïÇ)°Å¸®, ÁÖ¿ä(ñ«é©)
  • Goltzs syndrome => focal dermal hypoplasia
    ±¹¼Ò ÁøÇÇ Çü¼ººÎÀüÁõ
  • acral focal hyperkeratosis
    ¸»´Ü ±¹¼Ò °ú°¢È­Áõ
  • glomerulonephritis,focal embolic
    ÃÊÁ¡¼º »öÀü¼º
  • glomerulonephritis,focal proliferative
    ÃÊÁ¡¼º Áõ½Ä¼º
  • glomerulosclerosis,focal segmental
    ÃÊÁ¡¼º ºÐÀý¼º
  • infection, oral focal
    ±¸°­º´¼Ò°¨¿°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulopathy
    »ç±¸Ã¼º´Áõ.
  • acral focal hyperkeratosis
    ¸»´Ü ±¹¼Ò °ú°¢È­Áõ
  • dental focal infection
    Ä¡¾ÆÁ߽ɰ¨¿°(¡­ñéãýÊïæø).
  • familial focal facial dermal dysplasia
    °¡Á·¼º ±¹¼Ò ¾È¸é ÁøÇÇ ÀÌÇü¼º
  • focal acral hyperkeratosis
    ±¹¼Ò¼º ¸»´Ü °ú°¢È­Áõ
  • focal bacterial nephritis
    ±Þ¼º ±¹¼Ò¼º ¼¼±Õ¼º ½Å¿°
  • focal convulsive seizure
    ÃÊÁ¡¼º °æ·Ã¹ßÀÛ (õ¥ïÇàõÌâÕýÛ¡íÂ).
  • focal distance
    ÃÊÁ¡°Å¸®.
  • focal dyskeratosis
    ±¹¼Ò À̰¢È­Áõ
  • focal embolic encephalitis
    ÃÊÁ¡¼º »öÀü¼º ³ú¿°.
  • focal epilepsy =Jacksonian e.
    ÃÊÁ¡¼º °£Áú, ¿îµ¿ÁßÃß ¼Õ»ó¼º °£Áú(ê¡ÔÑ ñéõÒáßß¿àõÊÖòð), ÀÛ¼Õ°£Áú.
  • focal glomerulonephritis
    ÃÊÁ¡¼º »ç±¸Ã¼ ½Å¿°.
  • focal glomerulonephritis
    ÃÊÁ¡¼º »ç±¸Ã¼½Å¿°(¡­ÞêϹô÷ ãìæú)
  • focal glomerulosclerosis
    ÃÊÁ¡¼º »ç±¸Ã¼°æÈ­Áõ.
  • focal glomerulosclerosis
    ±¹¼Ò »ç±¸Ã¼°æÈ­
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sclerosing
    °æÈ­(¼º)ÀÇ
  • sclerosing agent
    °æÈ­¾à
  • sclerosing cholangitis
    °æÈ­¼º´ã°ü¿°
  • focal
    ÃÊÁ¡ÀÇ, º´¼ÒÀÇ
  • focal disease
    ÃÊÁ¡¼ºÁúȯ
  • focal distance
    ÃÊÁ¡°Å¸®
  • focal epilepsy
    ÃÊÁ¡¼º °£Áú, ¿îµ¿ ÁßÃß ¼Õ»ó¼º °£Áú, ÀÛ¼Õ°£Áú
  • focal glomerulonephritis
    ÃÊÁ¡¼º»ç±¸Ã¼½Å¿°
  • focal length
    ÃÊÁ¡±æÀÌ
  • focal lesion
    ÃÊÁ¡¼ºº´º¯
  • focal spot
    ±¹¼ÒÃÊÁ¡
  • focal zone
    ÃÊÁ¡¿µ¿ª
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FSGN focal sclerosing glomerulonephritis
PSC Primary Sclerosing Cholangitis
SSPE Subacute Sclerosing Pan-Encephalitis
ASHN acute sclerosing hyaline necrosis
NSHD nodular sclerosing Hodgkin disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NS Nodular Sclerosing
PSC Primary Sclerosing Cholangitis
SEP Sclerosing Encapsulating Peritonitis
SSPE Subacute Sclerosing Panencephalitis
NSHD nodular sclerosing Hodgkin disease
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • chronic diffuse sclerosing osteomyelitis
    ¸¸¼º ¹Ì¸¸¼º °æÈ­¼º °ñ¼ö¿°
    ¹Ì¸¸¼ºÀÇ Ä¡ÃßÁúȯ¿¡ ÀÇÇÑ °¨¿°¿¡¼­ ºñ·ÔµÈ´Ù. ³·Àº Á¤µµÀÇ °¨¿°¿¡ ´ëÇÑ °ñÀÇ Áõ½Ä¼º ¹ÝÀÀÀÌ´Ù. ³ë³âÃþÀÇ ¹«Ä¡¾Ç ºÎÀ§¿¡ ÁÖ·Î »ý±ä´Ù. Ưº°ÇÑ ¼Ò°ßÀº ¾ø´Ù. °ñÀÇ ¹Ì¸¸¼º °æÈ­°¡ ½ÉÇÏ°í ¾çÃø¼ºÀÌ´Ù. °æ°è´Â ºÒ¸í·áÇÏ´Ù. Á¶Á÷º´¸®ÇÐÀû ¼Ò°ßÀº Á¶¹ÐÇÏ°í ºÒ±ÔÄ¢ÇÑ °ñ¼ö, ¼¶À¯¼º °ñ¼ö°­ÀÌ´Ù.
  • sclerosing
    °æÈ­ÀÇ, °æÈ­¼ºÀÇ
  • sclerosing agent
    °æÈ­ ¾à, °æÈ­Á¦
  • sclerosing gastritis
    °æÈ­¼º À§¿°
  • sclerosing keratitis
    °æÈ­¼º °¢¸·¿°
    ºñÈļº °ø¸·¿°À» ¼ö¹ÝÇÏ´Â °¢¸·¿°.
  • sclerosing myelitis
    °æÈ­¼º ô¼ö¿°
  • sclerosing osteogenic sarcoma
    °æÈ­¼º °ñ À°Á¾
  • sclerosing seratitis
    °æÈ­¼º °¢¸·¿°
  • actual focal spot
    ½Ç ÃÊÁ¡
  • dental focal infection
    Ä¡¾Æ Á᫐ °¨¿°
    ±¹¼ÒÀûÀ¸·Î Á¡Ã³·³ »ý±ä Ä¡¾Æ °¨¿°.
  • effective focal spot
    ½ÇÈ¿ ÃÊÁ¡
  • focal atrophic
    ±¹¼ÒÀû À§Ãà
  • focal disease
    ÃÊÁ¡¼º Áúȯ
  • focal dystonia
    ±¹¼Ò¼º ±Ù±äÀå ÀÌ»ó
    ÀÌȯµÈ ±ÙÀ°¿¡¼­ ÀϽÃÀûÀ¸·Î Áö¼ÓµÇ´Â °æÃàÀÌ Æ¯Â¡ÀÎ ±¹¼ÒÀûÀÎ ±Ù ±äÀå ÀÌ»ó.
  • focal epilepsy
    ±¹¼Ò °£Áú, ÃÊÁ¡ °£Áú, ¿îµ¿ ÁßÃß ¼Õ»ó¼º °£Áú
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
focal sclerosing glomerulopathy Focal, segmental glomerulosclerosis reported in adults and children with normal serum complement, progressing to chronic glomerulonephritis.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
chronic focal sclerosing osteomyelitis A reaction of bone to a mild bacterial infection, often the result of a carious tooth, in persons with a high degree of tissue resistance; results in a localised radio-opacity.
Synonym: focal condensing osteitis.
(05 Mar 2000)
glomerulopathy Glomerular disease of any type.
Origin: Glomerulus + G. Pathos, suffering
(05 Mar 2000)
radial sclerosing lesion A variant of sclerosing adenosis of the breast with central scar formation and radiating hyperplastic ducts.
Synonym: radial scar.
(05 Mar 2000)
cholangitis, sclerosing Chronic, nonbacterial inflammatory narrowing of the bile ducts. About 50% of the cases are associated with ulcerative colitis. Treatment is to relieve the obstruction by balloon dilatation or surgery.
(12 Dec 1998)
chronic diffuse sclerosing osteomyelitis A proliferative reaction of bone to a low-grade infection of the jaws; most often seen in middle-aged or older black women as extensive, often bilateral radio-opacities of the mandible and maxilla.
(05 Mar 2000)
primary sclerosing cholangitis <radiology> Idiopathic, associated with IBD (50%), usually UC, M more than F, peak age 20-30 years of age, chronic inflammation and fibrosis of all bile ducts, stricture, obstruction, abscess (string of beads), intramural pseudo-diverticula, cholangiocarcinoma (10%!!), dilatation proximal to stricture may signal carcinoma Differential diagnosis: cholangiocarcinomarcinoma (diffuse form), primary biliary cirrhosis (PBC), AIDS-related cholangitis (? due to CMV)
(12 Dec 1998)
sclerosing adenosis A nodular, benign breast lesion occurring most frequently in relatively young women and consisting of hyperplastic distorted lobules of acinar tissue with increased collagenous stroma; the changes may be difficult to distinguish microscopically from carcinoma. Also, a benign nodular microscopic lesion of the prostate consisting of acimar tissue with increased stroma; the basal cell layer shows characteristic smooth muscle metaplasia.
Synonym: adenofibrosis, fibrosing adenomatosis, fibrosing adenosis.
(05 Mar 2000)
sclerosing agent A compound which acts by irritation of the veinous intimal epithelium; used in the treatment of varicose veins.
(05 Mar 2000)
sclerosing haemangioma <tumour> A benign lung or bronchial lesion, often subpleural, sometimes multiple, which forms hyalinised connective tissue.
Synonym: fibrous histiocytoma.
(05 Mar 2000)
sclerosing inflammation Inflammation leading to extensive formation of fibrous and scar tissue.
(05 Mar 2000)
sclerosing keratitis Inflammation of the cornea complicating scleritis; characterised by opacification of the corneal stroma.
(05 Mar 2000)
sclerosing leukoencephalitis <neurology> Chronic progressive illness seen in children a few years after measles infection and involving demyelination of the cerebral cortex. Virus apparently persists in brain cells: usually considered a slow virus disease.
(18 Nov 1997)
sclerosing mastoiditis A chronic mastoiditis in which the trabeculae are greatly thickened, almost or entirely obliterating the cells.
(05 Mar 2000)
sclerosing of varicose veins A procedure which involves the injection of a sclerosing agent (causes scarring) into varicose veins in the extremities. Sclerotherapy may also be performed in the oesophagus, using UGI endoscopy, in the treatment of oesophageal varices in patients with cirrhosis of the liver.
(27 Sep 1997)
sclerosing osteitis Fusiform thickening or increased density of bones, of unknown cause; it has been considered a form of chronic nonsuppurative osteomyelitis.
Synonym: condensing osteitis, Garre's disease.
Osteitis tuberculosa multiplex cystica, an osteitis of tuberculous origin, marked by numerous small cavities in the osseous substance.
Synonym: Jungling's disease.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • focal
    ÃÊÁ¡ÀÇ
  • focal distance
    ÃÊÁ¡°Å¸®
  • focal infection
    º´¼Ò°¨¿°
  • focal length
    ÃÊÁ¡°Å¸®
  • focal plane
    ÃÐÁ¡¸é(°³Æó½Ä¼ÅÅÍ)
  • focal plane shutter
    Æ÷Äà Ç÷¹ÀμÅÅÍ(»çÁø±âÀÇ ÃÊÁ¡¸é °³Æó ÀåÄ¡)
  • focal point
    ÃÊÁ¡
  • focal ratio
    =F-NUMBER
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á